DD

Damini Dhiman

Active Director Director DIN 10468831
DIN 10468831 First appointment Jan 2024 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Damini Dhiman

Data last updated:

Damini Dhiman is a Director at Exodrug Limited (since 2024). The company operates in Paper. Exodrug Limited reported revenue of ₹3.76 Cr (FY 2025).

DIN 10468831
Primary Designation Director
Industry Paper
First Appointment 17 Jan 2024
Oldest Company Age 2 yrs
Largest company Exodrug Limited · ₹3.76 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Exodrug Limited U21000HR2024PLC118145
Director17 Jan 20242024₹3.76 Cr (FY 2025)Active

Board colleagues of Damini Dhiman

NameDINCompanyDesignation
Kapil Dhiman10468829Exodrug LimitedDirector
Shubham Sharma10865025Exodrug LimitedDirector

Directorship timeline

Open interactive timeline →
Exodrug Limited
Premium access

Shareholding and investment profile for Damini Dhiman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Damini Dhiman

Damini Dhiman currently holds 1 directorship: Exodrug Limited (Director, since 17 Jan 2024, revenue ₹3.76 Cr (FY 2025)).

Damini Dhiman was first appointed on 17 Jan 2024 as Director at Exodrug Limited.

The current boards of Damini Dhiman's companies include Kapil Dhiman (Exodrug Limited), Shubham Sharma (Exodrug Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available